SOX-10 inhibitors comprises a diverse range of chemical entities that have been studied for their ability to modulate the activity of the SOX-10 transcription factor. SOX-10, a member of the SRY-related HMG-box (Sox) family, plays a crucial role in the development and maintenance of various cell types, particularly neural crest cells and their derivatives. These inhibitors have garnered attention primarily within the realm of research, aiming to dissect the intricate molecular mechanisms underlying neural crest cell biology and the broader regulatory networks involving SOX-10.SOX-10 inhibitors act by targeting specific components of the signaling pathways and transcriptional networks that govern SOX-10 expression and function. They exert their effects through a variety of mechanisms, such as interfering with key upstream regulators or modulating downstream effectors. Some inhibitors disrupt receptor-mediated signaling cascades, preventing the activation of kinases and co-factors that are critical for SOX-10 transcriptional activity. Others may influence the interaction of transcriptional co-regulators with the SOX-10 promoter region, thereby affecting its transcriptional output. In addition, certain compounds are known to interfere with broader signaling networks, such as the TGF-β and BMP pathways, which intricately intersect with SOX-10-related processes during neural crest development.
The chemical diversity within the SOX-10 inhibitors class enables researchers to dissect the precise molecular events that govern SOX-10's role in cell fate determination, differentiation, and migration. By selectively manipulating SOX-10 activity, these compounds offer a valuable toolkit for investigating the regulatory mechanisms underlying neural crest biology. As research tools, SOX-10 inhibitors contribute to expanding our understanding of the intricate interplay between transcription factors and signaling pathways during embryonic development and tissue homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $61.00 $82.00 | 15 | |
Inhibits SOX-10 expression by interfering with Ras membrane localization, leading to downstream inhibition of SOX-10 signaling. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Blocks Akt activation, which subsequently downregulates SOX-10 expression via the PI3K/Akt pathway. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $77.00 $153.00 $219.00 $663.00 $1248.00 $4382.00 $7850.00 | 8 | |
Alters TGF-β signaling by inhibiting the activin receptor-like kinases, thereby reducing SOX-10 expression. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
Blocks the TGF-β type I receptor, leading to decreased SOX-10 expression and potential modulation of neural crest development. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho-associated protein kinase (ROCK), impacting neural crest cell migration and possibly SOX-10-related processes. | ||||||
EW-7197 | 1352608-82-2 | sc-507465 | 5 mg | $345.00 | ||
Suppresses TGF-β signaling by inhibiting the ALK5 kinase, potentially influencing SOX-10 expression and neural crest development. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Blocks BMP type I receptors, impacting BMP signaling and indirectly affecting SOX-10 expression in neural crest cells. | ||||||
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $99.00 $216.00 $510.00 | 11 | |
Downregulates SOX-10 expression by modulating MAPK signaling pathways, which play a role in neural crest cell development. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
Inhibits adenosine kinase, leading to increased adenosine levels that may modulate signaling pathways related to SOX-10. | ||||||